Introduction
============

Harmful algal blooms occur when phytoplankton accumulate and negatively affect the environment and human or animal health. Harmful blooms are associated with a small subset of phytoplankton species. Out of 4,000 marine phytoplankton, it is estimated that some 200 are high biomass producers, and only \~80 are potential toxin-producers ([@r25]; [@r42]; [@r43]; [@r52]). Although naturally occurring in fresh, estuarine, and marine waters, the growth, toxicity, and geographic distribution of harmful algae have increased in part because of environmental factors such as nutrient enrichment and warmer water temperatures ([@r12]; [@r28]; [@r34]; [@r35], [@r36]; [@r41]). Most epidemiologic studies of harmful algal blooms, specifically those generated by cyanobacteria, have been conducted at freshwater sites. In the United States, freshwater harmful algal blooms have been associated with waterborne disease outbreaks that include dermatologic, gastrointestinal, respiratory, febrile, ear, and eye symptoms ([@r13]; [@r17]; [@r51]). The World Health Organization (WHO) has established guidelines for cell count categories associated with the risk of human health effects ([@r4]). The lowest guidance level of 20,000 cyanobacterial cells per milliliter was derived from an epidemiologic study of freshwater cyanobacteria exposure ([@r38]). Currently, there is no federal regulation of cyanobacteria or cyanotoxin exposure for recreational waters in the United States; however, several state and local governments have established guidelines for exposure based on their own risk assessments or those of the WHO ([@r7]).

Adverse human health outcomes have been associated with marine dinoflagellates, diatoms, and cyanobacteria ([@r50]). For example, harmful algal blooms produced by *Karenia brevis*, a marine dinoflagellate, have been reported to produce brevetoxins that are associated with gastrointestinal and respiratory illnesses ([@r2], [@r3]; [@r19]; [@r20]). *Lyngbya majuscula*, a benthic marine cyanobacterium, is known to produce toxins, such as debromoaplysiatoxin and lyngbyatoxin, and to cause acute dermal lesions among swimmers ([@r29]; [@r33], [@r32]; [@r31]; [@r50]). The picoplanktonic *Synechococcus*, a cyanobacterium, has been reported to produce microcystins, a group of potent hepatotoxic cyanotoxins ([@r8]). A limited number of epidemiologic studies have investigated the effects of harmful marine algal exposures, and most of these have focused on blooms of *K. brevis* ([@r2]; [@r20]). As a result, thresholds or concentrations of phytoplankton associated with adverse health effects are not well-established for marine waters.

Given the association between increasing ocean temperatures and increased frequency of harmful algal blooms around the world, there is a need to understand the impact of harmful algal blooms on human health as climate change progresses ([@r11]; [@r16]; [@r28]; [@r37]). The objective of the present study was to evaluate the association between phytoplankton cell counts and subsequent illness among recreational beachgoers at a tropical marine beach.

Methods
=======

We conducted a prospective study of beachgoers at Boquerón Beach, Puerto Rico, in the summer of 2009. We assessed the relationship between phytoplankton counts and the development of illness after recreational exposure. This study was in the context of the National Epidemiological and Environmental Assessment of Recreational (NEEAR) Water Study. A description of the study design, objectives, and protocols and a report of the associations between fecal indicator organisms and swimming-associated illness have been published ([@r47]).

*Site description.* Boquerón Beach is located on the southwest coast of Puerto Rico ([Figure 1](#f1){ref-type="fig"}). It is approximately 1 mile long and is located on Boquerón Bay, adjacent to the Caribbean Sea.

![Water sampling sites at Boquerón Beach.](ehp.1409558.g001){#f1}

*Interviews.* We offered beachgoers enrollment in the study at the beach on summer weekends and holidays for a total of 26 days. Inclusion criteria consisted of *a*) an adult household member \> 21 years of age; *b*) completion of three interviews (enrollment, beach exit, follow-up); and *c*) no previous participation in the study within the prior 28 days. An adult answered questions for all other household members at the beach. Interviews began at Boquerón Beach on 16 May 2009 and concluded on 2 August 2009.

Participants gave verbal informed consent for study participation in their chosen language, English or Spanish, and were interviewed by study personnel proficient in the language. All study materials were approved by the Institutional Review Board of the University of North Carolina at Chapel Hill. The enrollment interview collected information about demographics, baseline health, chronic health conditions, and contact information for follow-up. The exit interview collected information about water exposure and other activities in which the participants engaged while at the beach that day. Water exposure was ascertained with the following questions: "Did you immerse your body, not necessarily your head, in the water today?" "Did you put your face in the water or submerge your head in the water today?" and "Did you swallow the water?" The telephone interview, conducted 10--12 days later, recorded self-reported illness experienced since the beach visit. Participants were offered incentives, such as a cooler, a tote bag, or a beach-related item, to encourage completion of the exit interview. A US\$25 check was provided to each household after the follow-up telephone interview was completed.

*Health end points.* The health end points were defined *a priori* and were similar to those previously studied in relation to recreational water quality and health ([@r10]; [@r39]; [@r46]). They included incident cases of gastrointestinal (GI) illness, respiratory illness, rash (independent of sunburn), earache, and eye irritation occurring during the 10- to 12-day period between the beach visit and the follow-up telephone interview. The definitions for each illness are shown in [Table 1](#t1){ref-type="table"}. Signs and symptoms of each health end point were inquired about separately. For example, the following was asked for stomachache: "Have you or anyone else had a stomachache or abdominal cramping since the interview at Boquerón Beach?" Individual signs/symptoms of illness included the following: stomachache; diarrhea; nausea; vomiting; urinary tract infection; fever; headache; sore throat; cough; cold; runny or stuffy nose; earache, ear infection, or runny ears; watery eyes; eye infection; infected cut; and rash or itchy skin. For each question, participants could answer yes or no; they also had the option to refuse to answer or to say that they did not know.

###### 

Definitions and exclusion criteria for outcomes that occurred during the 10- to 12-day period between the beach visit and the follow-up telephone interview.

  Outcome                                                                       Definition                                                                                                                                                                 Baseline conditions^*a*^ excluded from analysis
  ----------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------
  Gastrointestinal illness                                                      Any of the following: diarrhea (≥ 3 loose stools in a 24-hour period); vomiting; nausea and stomachache; nausea or stomachache, and interference with regular activities   Gastrointestinal illness or vomiting
  Rash                                                                          Rash or itchy skin                                                                                                                                                         Rash
  Respiratory illness                                                           Any 2 of the following: sore throat, cough, runny nose, cold, or fever                                                                                                     Sore throat
  Earache                                                                       Earache, ear infection, or runny ears                                                                                                                                      Earache
  Eye irritation                                                                Eye irritation or infection, watery eye                                                                                                                                    Eye infection
  ^***a***^Baseline conditions occurred within 3 days before the beach visit.                                                                                                                                                                              

*Water samples.* Three fixed transects were selected at least 60 m apart to encompass the majority of the beach site. Water at sites along each transect was repeatedly sampled for marine phytoplankton counts and toxins; samples were collected from waist depth at each location at 1100 hours on each study day ([Figure 1](#f1){ref-type="fig"}). All samples were refrigerated or placed on ice within 30 min of collection and were maintained under refrigeration during shipment to GreenWater Laboratories/CyanoLab (Palatka, Florida) for analysis. Water samples were combined into a daily composite sample and were quantitatively assayed for total and group phytoplankton cell counts (cells per milliliter) by an experienced phycologist who used the counting method described in *Standard Methods for the Examination of Water and Wastewater* ([@r1]). The limit of detection using 5-mL samples at 100× magnification was 0.2 cells/mL. Water samples were also analyzed for two cyanobacterial toxins, lyngbyatoxin-a and debromoaplysiatoxin, using high-performance liquid chromatography--mass spectrometry (HPLC-MS) ([@r29]; [@r30]). These toxins were selected *a priori* based on the characteristics of the site; the limit of detection for both toxins was 1.0 ppb. Major phytoplankton groups were identified and included Cyanobacteria, Dinophyta (dinoflagellates), Bacillariophyta (diatoms), and miscellaneous other groups and morphotypes.

*Statistical analysis.* Multivariable logistic regression was used to evaluate the association between exposure to different categories of phytoplankton cell count and incidence of reported illness. The outcome was a binary indicator for each health end point as defined in [Table 1](#t1){ref-type="table"}. Each outcome was modeled separately. Each analysis excluded participants who reported having the outcome of interest in the 3 days before their beach visit.

Phytoplankton cell count was categorized as high (≥ 75th percentile), medium (\> 25th to \< 75th percentile), and low (≤ 25th percentile). The lowest category served as the referent in the regression models. Cell counts were considered in total and by phytoplankton group (e.g., Bacillariophyta, Cyanobacteria, Dinophyta). Picocyanophytes, a subgroup of Cyanobacteria, were examined separately from the Cyanobacteria group because they occurred at an order of magnitude higher than the other groups. To focus on those with recreational water contact, only participants who reported body immersion were included in models of the association between phytoplankton concentration and illness.

Covariates based on information from previous studies were considered for inclusion in the final model. Using frequency tables and chi-square tests, we identified factors associated with illness and/or water exposure to potential phytoplankton. These factors included age, sex, any other chronic illnesses, self-reported contact with algae, *Enterococcus* count, and digging in sand. After adjusting for different combinations of covariates, the association between phytoplankton exposure and incidence of reported illness varied by less than 0.1. The final model (adjusting for age and sex) was based on minimizing the Akaike information criterion (AIC) in order to balance model parsimony and fit. In sensitivity analyses, we considered other definitions of water exposure: head immersion and swallowing water. Duration of time spent in the water was evaluated as a potential effect measure modifier in stratified analyses.

Results
=======

*Respondent characteristics and demographics.* During the 26 study days, we included 15,726 individuals from 6,611 households. This represented 76% of the households initially approached and 96% of those completing the beach interview. There were slightly more female participants (55%), and nearly all (\> 99%) participants self-identified as Hispanic. The average age was 30 years (range: \< 1 to 92 years); children \< 12 comprised \< 20% of the study population. Approximately one quarter of all participants reported having a chronic illness: 13% reported having allergies, 11% reported having asthma, 5% reported having a chronic GI illness, and 3% reported having a chronic skin condition. Women reported more chronic illnesses, specifically chronic GI illness (6% women; 3% men; χ^2^ *p*-value \< 0.0001) and allergies (14% women; 11% men; χ^2^ *p*-value = 0.0004). Age categories (0--4 years; 5--11 years; 12--19 years; 20--34 years; 35--64 years; ≥ 65 years) revealed differences in chronic illness (χ^2^ *p*-value = 0.0002); chronic GI illness increased with age, reports of allergies were infrequent among the youngest participants (0--4 years), and reports of asthma were most frequent among children \< 12 years of age. Participants were excluded from analyses if they reported having the illness being evaluated in the 3 days before their beach visit. At enrollment, 8% of participants reported having a sore throat, and \< 3% reported vomiting, other GI illness, rash, eye irritation, or earache in the previous 3 days. [Table 2](#t2){ref-type="table"} summarizes the basic characteristics for all study participants and for those who reported body immersion in the water.

###### 

Characteristics of study population by level of water contact.

  Characteristic                                       *n* (%) of all participants (*n*= 15,726)   *n* (%) of participants reporting body immersion (*n*= 12,111)
  ---------------------------------------------------- ------------------------------------------- ----------------------------------------------------------------
  Sex                                                                                              
  Male                                                 7,052 (44.8)                                5,664 (46.8)
  Female                                               8,654 (55.0)                                6,431 (53.1)
  Missing                                              20 (0.1)                                    16 (0.1)
  Age category (years)                                                                             
  0--4                                                 908 (5.8)                                   764 (6.3)
  5--11                                                1,791 (11.4)                                1,678 (13.9)
  12--19                                               2,272 (14.5)                                1,940 (16.0)
  20--34                                               4,407 (28.0)                                3,422 (28.3)
  35--64                                               5,594 (35.6)                                3,866 (31.9)
  ≥ 65                                                 540 (3.4)                                   284 (2.3)
  Missing                                              214 (1.4)                                   157 (1.3)
  Ethnicity                                                                                        
  Non-Hispanic                                         104 (0.7)                                   75 (0.6)
  Hispanic                                             15,609 (99.3)                               12,027 (99.3)
  Missing                                              13 (0.1)                                    9 (0.1)
  Visits to this beach each summer                                                                 
  0--1                                                 4,592 (29.2)                                3,507 (29.0)
  2--5                                                 7,533 (47.9)                                5,841 (48.2)
  \> 5                                                 3,600 (22.9)                                2,762 (22.8)
  Missing                                              1 (0)                                       1 (0)
  Miles traveled to beach                                                                          
  0--20                                                5,161 (32.8)                                3,878 (32.0)
  20--60                                               5,597 (35.6)                                4,339 (35.8)
  60--100                                              2,795 (17.8)                                2,162 (17.9)
  \> 100                                               1,106 (7.0)                                 863 (7.1)
  Missing                                              1,067 (6.8)                                 869 (7.2)
  Baseline health in the 3 days prior to beach visit                                               
  Vomiting                                             130 (0.8)                                   97 (0.8)
  Other gastrointestinal illness                       309 (2.0)                                   232 (1.9)
  Sore throat                                          1,263 (8.0)                                 951 (7.9)
  Rash                                                 350 (2.2)                                   254 (2.1)
  Eye irritation                                       153 (1.0)                                   98 (0.8)
  Earache                                              224 (1.4)                                   164 (1.4)
  Chronic illness                                                                                  
  Any (gastrointestinal, skin, respiratory)            3,878 (24.7)                                2,992 (24.7)
  Chronic gastrointestinal illness                     756 (4.8)                                   545 (4.5)
  Chronic skin condition                               548 (3.5)                                   401 (3.3)
  Allergies                                            2,010 (12.8)                                1,540 (12.7)
  Asthma                                               1,684 (10.7)                                1,352 (11.2)

*Beach visit activities.* Upon leaving the beach, 77% of all participants reported body immersion in the water, 64% reported head immersion, and 36% reported getting water in their mouths. [Table 3](#t3){ref-type="table"} summarizes a sample of activities that participants reported engaging in at the beach. We analyzed the 12,111 participants (77%) who reported at least immersing their bodies in the water to improve the accuracy of exposure classification based on cell counts. As part of a sensitivity analysis, more substantial exposures were considered, including those who reported swallowing water as a marker of extreme exposure (*n* = 5,615). Among participants with body immersion, the mean duration spent in the water was just \> 2 hr. One quarter of all participants spent ≥ 3 hr in the water, and the maximum time spent in the water was 8 hr.

###### 

Activities reported at the beach exit interview.

  Activity                           *n*(%)
  ---------------------------------- ---------------
  All                                15,726 (100)
  No water contact                   2,995 (19.0)
  Total time spent in water          
  \< 60 min                          5,547 (35.3)
  60 to \< 120 min                   3,445 (21.9)
  120 to \< 180 min                  2,835 (18.0)
  ≥ 180 min                          3,892 (24.7)
  Body immersion                     12,111 (77.0)
  Head immersion                     10,074 (64.1)
  Water in mouth                     5,615 (35.7)
  Played with algae/seaweed          2,499 (15.9)
  Any contact with unknown animals   646 (4.1)
  Dug in sand                        3,699 (23.5)

*Illness after beach visit.* During the 10- to 12-day period between the beach visit and the follow-up telephone interview, respiratory illness was most commonly reported, with an overall incidence of 7%. The incidence was 5% for GI illness, 5% for rash, 3% for eye irritation, and 2% for earache.

*Water quality.* During the 26 study days, the median phytoplankton cell count was 712 cells/mL per day (range, 346--2,012 cells/mL). Of all groups identified, Bacillariophyta had the highest median (386 cells/mL per day). Cyanobacteria (excluding Picocyanophytes) had a median of 132 cells/mL per day. Picocyanophytes were only detected on 8 days but achieved a maximum count of 126,891 cells/mL. Dinophyta had a low median (37 cells/mL per day). Samples below the limit of detection (\< 0.2 cells/mL) were assigned a value of 0 for calculating phytoplankton distributions. [Table 4](#t4){ref-type="table"} summarizes the phytoplankton distribution over the study period.

###### 

Phytoplankton distribution over 26 days.

  Phytoplankton                                                                        Number (%) of days present   Minimum (cells/mL)   Maximum (cells/mL)   Mean (cells/mL)   Standard deviation (cells/mL)   25th percentile (cells/mL)   Median (cells/mL)   75th percentile (cells/mL)
  ------------------------------------------------------------------------------------ ---------------------------- -------------------- -------------------- ----------------- ------------------------------- ---------------------------- ------------------- ----------------------------
  All groups/phyla combined                                                            26 (100)                     345.7                2011.7               788.9             381.3                           581.6                        711.6               783.4
  Bacillariophyta                                                                      26 (100)                     128.6                619.4                377.5             102.6                           301.2                        385.9               442.5
  Cyanobacteria (excluding Picocyanophytes)                                            24 (92)                      0                    1460.8               254.4             379.4                           36.7                         131.6               237.4
  Picocyanophytes                                                                      8 (31)                       0                    126891.2             22606.4           38020.8                         0                            0                   45126.8
  Dinophyta                                                                            26 (100)                     0.2                  105.9                38.9              28.3                            23.5                         36.6                54.6
  Samples below the limit of detection (\< 0.2 cells/mL) were assigned a value of 0.                                                                                                                                                                             

Other phytoplankton groups were detected on \< 8 study days at very low cell counts. These groups included Haptophyta (mean = 8.6 cells/mL), Chrysophyta (mean = 2.8 cells/mL), Rhodophyta (mean = 0.7 cells/mL), Euglenophyta (mean = 0.2 cells/mL), and Chlorophyta (mean = 0.1 cells/mL). See Appendix 1 for a list of the genera and morphotypes that were identified and their distribution according to phytoplankton group. Concentrations of lyngbyatoxin-a and debromoaplysiatoxin were below the limit of detection of 1.0 ppb in every sample.

*Enterococcus* colony forming units (CFU) and phytoplankton counts were not correlated (Spearman's *r* = --0.14, *p*-value = 0.5). As previously reported by [@r47], low to moderate levels of fecal indicator bacteria were detected at Boquerón Beach, and the geometric means of the daily samples collected were all below the U.S. Environmental Protection Agency (EPA) guideline value of 35 CFU per 100 mL ([@r47]). Spearman's correlations between total phytoplankton counts and different environmental factors (e.g., wind speed and direction, air temperature, water temperature, turbidity) were all \< 0.3 (data not shown).

*Phytoplankton count and incident illness.* Among beachgoers who reported body immersion, the highest category of total phytoplankton cell count (≥ 75th percentile) was associated with eye irritation \[adjusted odds ratio (OR) = 1.30; 95% confidence interval (CI): 1.01, 1.66\], rash (OR = 1.27; 95% CI: 1.02, 1.57), and earache (OR = 1.25; 95% CI: 0.88, 1.77) ([Table 5](#t5){ref-type="table"}). Cyanobacteria cell counts were associated with respiratory illness, eye irritation, rash, and earache. These associations, although not all statistically significant at α = 0.05, strengthened with increasing Cyanobacteria cell count categories ([Figure 2](#f2){ref-type="fig"}). In particular, respiratory illness, rash, and earache all had associations that increased relatively monotonically with each Cyanobacteria cell count category. Respiratory illness had the strongest association with all Cyanobacteria cell count categories. [Table 5](#t5){ref-type="table"} shows the associations between phytoplankton group cell count and incident illness among beachgoers who reported body immersion.

###### 

Associations between phytoplankton cell counts and incident illness occurring during the 10- to 12-day period between the beach visit and the follow-up telephone interview among beachgoers who reported body immersion in water.

  Phytoplankton group                                                                                                                                                                                                                                     Gastrointestinal illness (*n*= 11,832)   Respiratory illness (*n*= 11,160)   Eye irritation (*n*= 12,013)   Rash (*n*= 11,857)   Earache (*n*= 11,947)                                                                   
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------- ----------------------------------- ------------------------------ -------------------- ----------------------- ------------------- ----------- ------------------- ----------- -------------------
  All groups combined                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  ≤ Q1                                                                                                                                                                                                                                                    174 (5.0)                                1                                   227 (6.9)                      1                    114 (3.2)               1                   156 (4.5)   1                   57 (1.6)    1
  \> Q1 to \< Q3                                                                                                                                                                                                                                          211 (4.5)                                0.91 (0.74, 1.12)                   315 (7.1)                      1.03 (0.86, 1.23)    144 (3.0)               0.93 (0.72, 1.19)   199 (4.2)   0.95 (0.77, 1.18)   96 (2.0)    1.25 (0.90, 1.74)
  ≥ Q3                                                                                                                                                                                                                                                    178 (4.9)                                1.00 (0.80, 1.24)                   244 (7.1)                      1.02 (0.85, 1.24)    155 (4.2)               1.30 (1.01, 1.66)   206 (5.6)   1.27 (1.02, 1.57)   76 (2.1)    1.25 (0.88, 1.77)
  Bacillariophyta                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  ≤ Q1                                                                                                                                                                                                                                                    142 (4.4)                                1                                   189 (6.1)                      1                    110 (3.3)               1                   170 (5.2)   1                   54 (1.6)    1
  \> Q1 to \< Q3                                                                                                                                                                                                                                          281 (5.0)                                1.13 (0.92, 1.39)                   405 (7.7)                      1.28 (1.07, 1.54)    223 (3.9)               1.18 (0.94, 1.49)   279 (5.0)   0.97 (0.80, 1.18)   118 (2.1)   1.29 (0.93, 1.79)
  ≥ Q3                                                                                                                                                                                                                                                    140 (4.7)                                1.06 (0.83, 1.35)                   192 (6.8)                      1.10 (0.89, 1.35)    80 (2.7)                0.78 (0.58, 1.05)   112 (3.8)   0.73 (0.57, 0.94)   57 (1.9)    1.15 (0.79, 1.68)
  Cyanobacteria                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  ≤ Q1                                                                                                                                                                                                                                                    173 (5.0)                                1                                   187 (5.8)                      1                    114 (3.3)               1                   144 (4.2)   1                   55 (1.6)    1
  \> Q1 to \< Q3                                                                                                                                                                                                                                          226 (4.4)                                0.87 (0.71, 1.06)                   354 (7.4)                      1.30 (1.08, 1.56)    161 (3.1)               0.96 (0.75, 1.22)   236 (4.6)   1.12 (0.90, 1.39)   101 (2.0)   1.25 (0.89, 1.74)
  ≥ Q3                                                                                                                                                                                                                                                    164 (5.0)                                0.98 (0.79, 1.22)                   245 (7.8)                      1.37 (1.12, 1.67)    138 (4.1)               1.25 (0.97, 1.62)   181 (5.5)   1.32 (1.05, 1.66)   73 (2.2)    1.35 (0.95, 1.93)
  Picocyanophytes                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  None                                                                                                                                                                                                                                                    397 (4.8)                                1                                   527 (6.7)                      1                    281 (3.3)               1                   407 (4.9)   1                   155 (1.8)   1
  Any                                                                                                                                                                                                                                                     166 (4.7)                                0.96 (0.80, 1.16)                   259 (7.8)                      1.13 (0.97, 1.32)    132 (3.7)               1.10 (0.89, 1.36)   154 (4.3)   0.90 (0.74, 1.09)   74 (2.1)    1.11 (0.83, 1.47)
  Dinophyta                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  ≤ Q1                                                                                                                                                                                                                                                    128 (4.5)                                1                                   192 (7.2)                      1                    96 (3.3)                1                   151 (5.3)   1                   64 (2.2)    1
  \> Q1 to \< Q3                                                                                                                                                                                                                                          275 (5.3)                                1.22 (0.98, 1.51)                   358 (7.2)                      1.01 (0.84, 1.21)    185 (3.5)               1.04 (0.81, 1.33)   243 (4.6)   0.84 (0.68, 1.04)   87 (1.6)    0.72 (0.52, 1.01)
  ≥ Q3                                                                                                                                                                                                                                                    160 (4.3)                                0.97 (0.76, 1.23)                   236 (6.7)                      0.95 (0.78, 1.15)    132 (3.5)               1.05 (0.80, 1.37)   167 (4.4)   0.82 (0.65, 1.03)   78 (2.1)    0.93 (0.67, 1.30)
  Abbreviations: CI, confidence interval; OR, adjusted odds ratio; Q1, 25th percentile; Q3, 75th percentile. Models adjusted for age (as a continuous variable) and sex. Denominator for the case percentage is the total number in the exposure group.                                                                                                                                                                                                                            

![Associations between Cyanobacteria cell count and illness among beachgoers who reported body immersion in water. Models adjusted for age (as a continuous variable) and sex. Q1 = 25th percentile; Q3 = 75th percentile.](ehp.1409558.g002){#f2}

Picocyanophytes were not associated with any subsequent illness among participants who reported body immersion in the water ([Table 5](#t5){ref-type="table"}). However, among those who reported swallowing water (*n* = 5,615), the presence of Picocyanophytes was significantly associated with earache (OR = 1.62; 95% CI: 1.14, 2.30), which was reported by 3.3% (*n* = 56) of those exposed and 2.1% (*n* = 83) of those unexposed. Similarly, among participants who reported swallowing water, the highest category of Cyanobacteria cell count was associated with earache (OR = 1.75; 95% CI: 1.09, 2.82), which was reported by 3.2% (*n* = 52) of those exposed to the highest category and 1.8% (*n* = 29) of those exposed to the lowest category.

As shown in [Table 5](#t5){ref-type="table"}, the medium category of Bacillariophyta was associated with respiratory illness (OR = 1.28; 95% CI 1.07, 1.54); however, the odds ratio did not increase for the highest category (OR = 1.10; 95% CI: 0.89, 1.35). Exposure to Dinophyta was not associated with any illness.

To assess potential effect measure modification by the length of time spent in water, we conducted analyses stratified by number of hours spent in the water (\< 1 hr, 1 to \< 2 hr, 2 to \< 3 hr, ≥ 3 hr). We also restricted our analysis to other categories of water exposure (head immersion, swallowing water). The results were similar in the stratified analyses, with the exception of a stronger earache association with Cyanobacteria and Picocyanophytes after restricting to participants who reported swallowing water (data not shown).

Discussion
==========

We report the results of a prospective evaluation of the health effects associated with recreational water exposure to marine phytoplankton in the absence of a harmful algal bloom. Given the popularity of visiting beaches ([@r21]) and the apparent increase in harmful algal blooms around the world ([@r41]), we sought to better understand the effects of marine phytoplankton on human health. We found an association between total phytoplankton cell count and incident illness: specifically, eye irritation and rash. These outcomes have also been associated with freshwater blooms ([@r5]; [@r38]; [@r40]; [@r48]).

Our study design established a temporal sequence between exposure and outcome. By having interviews performed at different time points, participants did not have to wait a long time to recall their experiences, and their exposure response could not be influenced by any subsequent illness. The high participation rate (\> 75%) reduced the possibility of selection bias. After considering a range of potential confounders, we only adjusted for age (as a continuous variable) and sex in order to balance model parsimony and fit. Because our final model produced similar results to those of the full model (adjusting for age, sex, any other chronic illnesses, self-reported contact with algae, *Enterococcus* count, and digging in sand), there did not appear to be a major bias due to confounding (data not shown).

Our study design allowed one adult to answer questions for all other household members at the beach. Although there was a possibility for responder bias or misinformation, there was an average of only 3.2 individuals per household, and other household members often assisted with the questionnaire responses. A limitation of our self-reported outcome data was a lack of specific details about some of the illnesses. Therefore, it was difficult to confirm the etiology of the illness on the basis of the participant responses alone. For example, we could not necessarily distinguish among rashes as being associated with cnidarians, sea lice, cercariae, salt water itself, or even something completely unrelated to the beach visit.

Cyanobacteria concentration was associated with all illnesses except GI illness; the odds of illness increased with cell count category. Our findings were consistent with reports of skin and eye irritations associated with *Lyngbya majuscula* blooms ([@r32]; [@r31]). Despite these similar illnesses, the *Lyngbya*-associated toxins, debromoaplysiatoxin and lyngbyatoxin-a, were below the limit of detection in all samples, and *Lyngbya* comprised only 3% of total planktonic Cyanobacteria among samples (see Appendix 1). Debromoaplysiatoxin and lyngbyatoxin-a are photolabile and are unlikely to persist in the water column ([@r27]). It is possible that people had contact with toxins or toxic material in the water or on the ocean floor because we did not sample the seabed or measure other cyanotoxins potentially associated with Cyanobacteria.

Unlike previous epidemiologic studies of freshwater cyanobacterial blooms ([@r22]; [@r38]), GI illness was the only illness that did not appear to be associated with marine Cyanobacteria in the absence of blooms, even when we restricted the analysis to participants who reported swallowing water. Although the lack of association with GI illness may have been because of low Cyanobacteria cell counts, health effects may also differ after exposure to communities of Cyanobacteria in fresh and marine waters. The maximum Cyanobacteria cell count (excluding Picocyanophytes) was 1460.8 cells/mL. In epidemiologic studies conducted at freshwater sites, illnesses were associated with cyanobacterial counts \> 5,000 cells/mL ([@r38]) and at counts \< 20,000 cells/mL relative to no water contact ([@r22]). More work is needed to define Cyanobacteria concentrations that are safe for human health in marine waters.

We analyzed Picocyanophytes separately because of the different orders of magnitude of the cell counts. Although most of the cyanobacteria literature describes marine picoplankton as nontoxic, there are some reports of toxic effects caused by homogenized *Synechococcus* and *Synechocystis* and their extracts ([@r24], [@r23]; [@r49]). Microcystins have been shown to cause adverse health effects ([@r9]; [@r14]; [@r15]), and a study of *Synechococcus* strains suggested that some marine picoplankton may be capable of synthesizing microcystins ([@r8]).

We observed an association between earache and Cyanobacteria among those who reported swallowing water. This finding is consistent with the positive but nonsignificant association we estimated among all those who immersed themselves in water. In the context of earache, we hypothesize that the stronger association, when restricted to those who swallowed water, may reflect more frequent head immersion and more intense exposure overall rather than being a direct consequence of swallowing water. Earache has been associated with swimming, especially when the head is immersed ([@r45]). The presence of any Picocyanophytes (vs. none detected) was associated with earache among participants who reported swallowing water. To our knowledge, this association has not been previously reported.

Associations with specific outcomes varied among other phytoplankton groups. Bacillariophyta cell counts in the 25th to 75th percentile range, but not counts above the 75th percentile, were significantly associated with respiratory illness when compared with counts below the 25th percentile. To our knowledge, Bacillariophyta have not been associated with respiratory illness in previous studies. Previous studies of marine diatoms, such as those of the genus *Pseudo-nitzschia* that produce domoic acid, have focused on adverse outcomes occurring after ingestion of contaminated shellfish rather than on recreational water exposure ([@r44]).

Because phytoplankton cell counts were low, we cannot be confident that associations with health outcomes were a result of phytoplankton exposure alone, or if phytoplankton were markers for other unmeasured causative factors, such as potentially pathogenic microbes or physical-chemical conditions associated with marine phytoplankton. In addition, we are unable to rule out noncausal mechanisms related to chance or bias (e.g., uncontrolled confounding, selection bias, information bias). Although phytoplankton may provide nutrients and substrates for the survival of microbial communities, there is limited knowledge on the occurrence of phytoplankton-associated pathogens ([@r6]; [@r26]).

We categorized cell count *a priori* as high (≥ 75th percentile), medium (\> 25th to \< 75th percentile), and low (≤ 25th percentile) because health guidelines for concentrations of marine phytoplankton have yet to be established. As a result, it is possible that the highest cell count category was actually below any level that could cause potential adverse health effects. For example, although we did not find an association of illness with Dinophyta, maximum cell counts for Dinophyta were only 105.9 cells/mL. In contrast, epidemiologic studies of the marine dinoflagellate, *K. brevis*, and associated respiratory illness measured maximum cell counts ranging from 8,120 cells/mL ([@r2]) to 121,000 cells/mL ([@r3]).

We reported cell counts per milliliter of water so that our findings could be compared with those of previous studies and the WHO guidelines for freshwater exposures ([@r4]). A limitation of our phytoplankton assessment was that we had no information on cell size to calculate biomass concentrations. Cell size can influence total phytoplankton exposure. For example, a few large cells of one species may contribute more to the overall biomass than many small cells of a different species ([@r18]).

Finally, our study participants spent a large amount of time in the water; half of them spent ≥ 2 hr in the water. It is possible that we observed associations between health outcomes and low phytoplankton counts, in the absence of active phytoplankton blooms, because the participants spent so much time in the water. However, the associations did not vary significantly when stratified by total time in the water (data not shown).

Our results offer insight into the potential health effects of marine phytoplankton in the absence of a harmful algal bloom. Although some associations could be due to chance or bias, most seem plausible based on the existing literature. The evaluation of health effects associated with recreational exposure to marine phytoplankton at sub-bloom concentrations warrants further investigation.

Conclusions
===========

We found associations between recreational exposure to marine phytoplankton and subsequent reports of eye irritation, respiratory illness, earache, and rash at a tropical beach in the absence of an algal bloom. In addition, we found that associations varied by phytoplankton group, with Cyanobacteria having the strongest associations with most of the outcomes assessed.

Appendix 1: Genera/morphotypes by phytoplankton group (percentage within each group)
------------------------------------------------------------------------------------

**Bacillariophyta (69% of total phytoplankton)**

Pennate diatom (37); Nitzschia (12); Navicula (7); Licmophora (5); Bacillaria (4); Cylindrotheca/Nitzschia (4); Amphiprora (4); Psammodictyon (4); Chaetoceros (3); Centric diatom (3); Diploneis (2); Amphora (2); Rhizosolenia (2); Amphiprora/Plagiotropis (1); Actinocyclus/Coscinodiscus (1); Proboscia (1); Skeletonema (1); Cocconeis (1); Gyrosigma/Pleurosigma (1); Actinoptychus (1); Bacteriastrum (1); Diatom (1); Paralia (1); Achnanthes (\< 1); Plagiotropis (\< 1); Pseudo-nitzschia (\< 1); Triceratium (\< 1); Attheya (\< 1); Guinardia (\< 1); Gyrosigma (\< 1); Odontella (\< 1); Peralia (\< 1); Tropidoneis (\< 1)

**Dinophyta (13% of total phytoplankton)**

Dinoflagellate (67); Gonyaulax (16); Ceratium (7); Prorocentrum (7); Amphidinium (1); Dinophysis (1); Protoperidinium (1)

**Cyanobacteria (9% of total phytoplankton)**

Cyanophyte filament (32); Pseudanabaena (26); Picocyanophyte (10); Synechococcus (5); Synechocystis (5); Cyanophyte cell pair (5); Phormidium (4); Lyngbya (3); Trichodesmium (3); Aphanothece (1); Johannesbaptistia (1); Komvophoron (1); Cyanophyte colony (1); Cyanophyte unicell, sphere 2.5--5 μm (1)

**Miscellaneous (8% of total phytoplankton)**

Unknown flagellate (29); Unicell, sphere 2.5--5 μm (26); Unicell, oval 2.5--5 μm (14); Unknown unicell (11); Unicell, oval 5--7.5 μm (10); Microflagellate (4); Unicell, oval/rod 2.5--5 μm (3); Unicell, sphere 5--7.5 μm (1); Unknown filament (1)

**Haptophyta (0.8% of total phytoplankton)**

Haptophyte flagellate (100)

**Euglenophyta (0.6% of total phytoplankton)**

Euglenophyte (80)

Euglena/Eutreptiella (20)

**Chrysophyta (0.2% of total phytoplankton)**

Chrysophyte flagellate (100)

**Rhodophyta (0.2% of total phytoplankton)**

Rhodophyte filament (100)

**Chlorophyta (0.1% of total phytoplankton)**

Chlorophyte filament (100)
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